References
Zou BZ, Wen H, Luo HJ et al (2023) Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer. Ir J Med Sci. https://doi.org/10.1007/s11845-023-03448-w. Epub ahead of print. PMID: 37414978
Lin FX, Zhao L, Liu JM et al (2017) Free prostate specific antigen density predicts prostate cancer with high accuracy. Biomed Res 28:7806–7809
Siddiqui MR, Ansbro B, Shah PV et al (2023) Real-world use of MRI for risk stratification prior to prostate biopsy. Prostate Cancer Prostatic Dis 26(2):353–359. https://doi.org/10.1038/s41391-022-00543-4. Epub 2022 May 12 PMID: 35551235
Acknowledgements
This work has not been presented anywhere else.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The authors have no ethical conflicts to disclose.
Informed consent
All authors consent to the publication of the article.
Conflict of interest
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lin, FX., Xu, ZP. Serum free prostate-specific antigen density (fPSAD) as a predictor of prostate cancer: a new parameter worthy of attention. Ir J Med Sci 193, 627–628 (2024). https://doi.org/10.1007/s11845-023-03533-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-023-03533-0